IJzermans JN - Search Results

1

Successful expansion of the living donor pool by alternative living donation programs.

Roodnat JI, Kal-van Gestel JA, Zuidema W, van Noord MA, van de Wetering J, IJzermans JN, Weimar W. Roodnat JI, et al. Among authors: ijzermans jn. Am J Transplant. 2009 Sep;9(9):2150-6. doi: 10.1111/j.1600-6143.2009.02745.x. Epub 2009 Jul 16. Am J Transplant. 2009. PMID: 19624564 Free article.

2

The effect of hydergine on cyclosporine-induced nephrotoxicity in kidney allografted rats.

Ijzermans JN, Singh SK, de Bruin RW, Bouwman E, Weimar W, Marquet RL, Jeekel J. Ijzermans JN, et al. Transplant Proc. 1987 Feb;19(1 Pt 2):1385-6. Transplant Proc. 1987. PMID: 3274337 No abstract available.

3

Successful treatment of Kaposi's sarcoma in a renal allograft recipient.

Marsman WA, Van Gelder T, Mulder AH, Ijzermans JN, Zietse R, Weimar W. Marsman WA, et al. Among authors: ijzermans jn. Nephrol Dial Transplant. 1995;10(6):900-1. Nephrol Dial Transplant. 1995. PMID: 7566628 No abstract available.

4

Glomerular barrier function following conversion from cyclosporine to azathioprine in renal transplant recipients.

Zietse R, van Ierland-van Leeuwen ML, Derkx FH, Ijzermans JN, Schalekamp MA, Weimar W. Zietse R, et al. Among authors: ijzermans jn. Am J Kidney Dis. 1994 Dec;24(6):927-31. doi: 10.1016/s0272-6386(12)81063-8. Am J Kidney Dis. 1994. PMID: 7985671

5

Effect of isradipine on cyclosporin A-related hypertension.

van den Dorpel MA, Zietse R, Ijzermans JN, Schalekamp MA, Weimar W. van den Dorpel MA, et al. Among authors: ijzermans jn. Blood Press Suppl. 1994;1:50-3. Blood Press Suppl. 1994. PMID: 8205301 Clinical Trial.

6

Single-shot, high-dose rabbit ATG for rejection prophylaxis after kidney transplantation.

Zietse R, van Steenberge EP, Hesse CJ, Vaessen LB, IJzermans JN, Weimar W. Zietse R, et al. Among authors: ijzermans jn. Transpl Int. 1993;6(6):337-40. doi: 10.1007/BF00335971. Transpl Int. 1993. PMID: 8297463

7

Mycophenolate mofetil and prednisone as maintenance treatment after kidney transplantation.

van Gelder T, Klaassen RJ, van Riemsdijk-van Overbeeke I, IJzermans JN, Weimar W. van Gelder T, et al. Among authors: ijzermans jn. Transplantation. 1997 May 27;63(10):1530-1. doi: 10.1097/00007890-199705270-00029. Transplantation. 1997. PMID: 9175824

8

Relation of mycophenolic acid trough levels and adverse events in kidney allograft recipients.

Smak Gregoor PJ, Hesse CJ, van Gelder T, van der Mast BJ, IJzermans JN, van Besouw NM, Weimar W. Smak Gregoor PJ, et al. Among authors: ijzermans jn. Transplant Proc. 1998 Jun;30(4):1192-3. doi: 10.1016/s0041-1345(98)00204-8. Transplant Proc. 1998. PMID: 9636482 No abstract available.

9

Randomized trial to evaluate the use of increasing the steroid dose during conversion from cyclosporine to azathioprine.

Roodnat JI, Zietse R, Rischen-Vos J, van Gelder T, IJzermans JN, Weimar W. Roodnat JI, et al. Among authors: ijzermans jn. Transplant Proc. 1998 Jun;30(4):1199-200. doi: 10.1016/s0041-1345(98)00208-5. Transplant Proc. 1998. PMID: 9636486 Clinical Trial. No abstract available.

10

The vanishing importance of age in renal transplantation.

Roodnat JI, Zietse R, Mulder PG, Rischen-Vos J, van Gelder T, IJzermans JN, Weimar W. Roodnat JI, et al. Among authors: ijzermans jn. Transplantation. 1999 Feb 27;67(4):576-80. doi: 10.1097/00007890-199902270-00015. Transplantation. 1999. PMID: 10071030

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

712 results

Search Page